actively participates in the European infrastructure of biobanks and biomolecular resources (BBMRI-ERIC) and in its Italian National Node of BBMRI.it. It also participates in an international working group on biobanks sustainability [9] and in the BRIF initiative [10] . Biological samples and associated data.
Classification (1)
Human
Context: Spatial coverage
The Bank is located in Genoa, Italy The cell lines have been produced and deposited in the bioresource by researchers based both in Italy and in other countries.
The services of the Bank are provided worldwide.
Temporal coverage for accessibility
From 01/11/1994 on. Expected date of last inclusion: unknown.
(2) Methods

Steps
The cell lines of the ICLC catalogue are either produced within the Institute where the bioresource is based or collected from external researchers, and subsequently deposited by the originator. The authorized use of the cell line is specified in the Deposit sheet. The cells undergo a first quality control (identity, sterility, mycoplasma) and are then expanded and preserved. Master and Working/ Distribution Banks are produced and each batch is fully quality controlled. When the cell line is available for distribution and the depositor has agreed upon its description, the information is included in the on-line catalogue.
The cell lines are distributed to qualified researchers, through a Material Transfer Agreement. Standard Operating Procedures are available for each step of the process: access of the cell lines to the bank, management, quality control, identification, storage, catalogue and distribution.
Stabilization/preservation
Cryopreservation in two milliliter cryovials, Foetal Bovine Serum 50-95%, culture medium 0-40%, Dimethylsulfoxide (DMSO) 5-10%.
Type of long-term preservation
Frozen in gas phase liquid nitrogen refrigerators.
Storage temperature
−135°C to −190°C (liquid nitrogen vapours and liquid nitrogen).
Shipping temperature from source to preservation or research use
The cell lines are either produced within the Institute or collected from external researchers, and subsequently deposited. The shipping temperature is either −60 to −78,5°C (dry ice), or room temperature (flasks in culture 18-25°C).
Shipping temperature from storage to research use −60 to −78,5°C (dry ice); room temperature (flasks in culture 15-25°C)
Quality assurance measures
The 1. The personnel of the bank is fully trained and highly experienced, training is fully documented 2. Standard Operating Procedures available for each step of the processes of the bank, including training; traceability guaranteed through registration of each step of the biobanking process 3. Periodic audits are performed by the Quality office of the Institute, and fully documented 4. Cell lines are kept in a quarantine lab until quality control has been completed 5. All human cell lines are identified through Short
Tandem Repeat profile and a certificate is provided to the users 6. All batches of cell lines are tested for mycoplasma (two validated assays), bacteria and fungi 7. Master and working/distribution banks are produced for each cell line of the catalogue 8. Remote wireless monitoring system of temperature, pressure, CO 2 , humidity for relevant equipment (freezers, incubators, cell culture laboratories), freezers equipped with alarms for immediate intervention in case of black-out 9. All cell lines preserved in at least two separated liquid nitrogen containers 10. Controlled access to the facility and to the document archive 11. Controlled access to the computers and daily backup of relevant files.
Source of associated data
Questionnaire to the depositor, experimental data, results of previous studies on the cell lines, scientific literature, return of results from users.
Ethics Statement
The ICLC cell bank belongs to the institutional Biological Resource Centre, which has produced an Ethical Code, a Consent form and a Material Transfer Agreement form, approved by the local Ethics Committee (March 8th, 2010). Disposal of biological samples no longer in use is performed following the institutional procedure: biohazardous wastes are inactivated (autoclaved or bleach treated) and placed into the medical waste boxes provided by the hospital.
Constraints
N/A (3) Bioresource description Object name
Disease-oriented biobank: established human and animal cell lines Mainly cancer
Pathology diagnosis
The description of diagnosis is made on the basis of controlled terms for tumours and pathologies.
Control samples
N/A
Biospecimen type
Cell lines Aliquots: cryovials containing 2 -5 × 10 6 cells. The batch size is 10-30 samples.
Size of the bioresource
The catalogue of the bioresource contains 210 human cell lines and 77 animal cell lines, derived from 43 animal species. A total number of about 6.500 frozen ampoules is stored. Most human cell lines (189) and animal cell lines (61) are derived from tumours.
A subset of cell lines (71) was received from the European Collection of Animal Cell Cultures (ECACC) in the frame of the European project Biomedicine and Health (BIOMED 2) 1994-1998.
The growth of the Bank depends on several variables. A growth of 5 to 10% yearly is foreseen.
Release date
The resource is available since November 1994
Access criteria
The bioresource deals with established cell lines, which are virtually immortal. Therefore, there is no need for a strict prioritization policy. The catalogue is available on-line both through the ICLC website (www.iclc. it) and through other sources (Cell Line Data Base, CABRI). The request form is available on-line both in Italian and in English, together with the Material Transfer Agreement and the instructions for ordering. The MTA states that ". . . The cell lines are distributed, as frozen ampoules, growing cultures or genomic DNA, to qualified researchers, who are responsible of their correct preservation and use. In order to receive the cell line(s) the researcher must . . . confirm that he/she is authorized to receive, on behalf of his/her employer, the cell line(s) requested . . .". In addition: ". . . In case the cell line(s) belongs to the Biological Level 2 containment, this is clearly specified in the technical sheet; the researcher confirms that he/she has access to adequate laboratories . . .". Beside this, no restriction is applied, and the cells are shipped anywhere in the world, to countries that accept dry ice shipments and which can be reached in a maximum of 5 days. The cost recovery for frozen cell lines is € 270 plus shipment; an extra cost of € 100 is charged for Class 2 Genetically Modified Organisms (GMOs).
(4) Reuse potential
Recently, the authentication of established human cell lines through STR profiling has become mandatory for publication of papers where human cell lines are used. The wide use of this international standard adds reliability to the results of research. Uncontrolled exchange of non-authenticated cell lines is now finally seen as a danger for the quality of research, and cell banks providing the service of authentication are now much more used. Researchers producing new cell lines can "protect" their work by publishing the molecular profile, thus providing a reference for authentication. Likewise, researchers using the cell lines can be confident that the results previously published have been obtained with cell lines whose molecular profile has been identified and confirmed.
The ICLC Material Transfer Agreement states that ". . . If the cell lines are referred to in any publication, the ICLC catalogue code will be included, and reference to the original paper will be added . . .". Whenever possible, ICLC updates the description of the cell lines in the catalogue with data produced and published by the researchers who have obtained the cell lines, by adding the new references to the "Further bibliography" field.
